Internal Medicine, Medical Oncology · Katy, TX
NPI
1023088853
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
410 W Grand Pkwy S Ste 4c
Katy, TX, 77494
Phone (281) 647-7766
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,972 services
Medicare patients, 2024
117
Average age 72
Drug cost, 2024
$1.8M
2,514 prescriptions
Company payments, 2025
$228
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shagufta N Naqvi IV was code 99214 (office e&m - established), 203 times for 113 patients. In total Shagufta N Naqvi IV billed 1,972 services in 30 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 203 | 113 | $97.56 | $20K |
By year: 2022 $1.1M for 52,182 services; 2023 $93K for 3,194 services; 2024 $45K for 1,972 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shagufta N Naqvi IV prescribed most often to Medicare patients was Pregabalin, with 189 prescriptions and refills. In total Shagufta N Naqvi IV wrote 2,514 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pregabalin Generic | 189 | 232 | 37 | $5,694 |
| Clonazepam Generic | 186 | 228 | 33 | $1,403 |
| Tramadol Hcl Generic | 130 | 134 | 36 | $1,627 |
| Raloxifene Hcl Generic | 107 | 224 | 24 | $2,891 |
| Letrozole Generic | 96 | 223 | 26 | $2,019 |
| Gabapentin Generic | 92 | 135 | 19 | $1,289 |
| Alprazolam Generic | 85 | 122 | 19 | $480 |
| Exemestane Generic | 84 | 129 | 14 | $6,207 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 82 | 82 | 25 | $1,906 |
| Pantoprazole Sodium Generic | 82 | 200 | 23 | $608 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 81 | 142 | 14 | $884 |
| Eliquis Apixaban | 76 | 100 | 11 | $58K |
| Levothyroxine Sodium Generic | 67 | 139 | 19 | $384 |
| Tamoxifen Citrate Generic | 61 | 113 | 14 | $1,364 |
| Fluoxetine Hcl Generic | 51 | 117 | 12 | $659 |
Brand drugs: 306 claims; generic drugs: 2,191 claims; opioid claims: 278.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shagufta N Naqvi IV $228 ($228 in general payments such as food, travel and fees) from 8 companies. The largest payer was Eisai Inc. with $60.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.